M&T Bank Corp Procept Bio Robotics Corp Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$45.73 - $69.19 $139,979 - $211,790	-3,061 Reduced 29.79%	7,214 $440,000
Q1 2024 May 07, 2024	SELL	$40.38 - $50.75 $9,610 - $12,078	-238 Reduced 2.26%	10,275 $507,000
Q4 2023 Feb 06, 2024	BUY	$24.89 - $43.41 $39,599 - $69,065	1,591 Added 17.83%	10,513 $440,000
Q3 2023 Nov 02, 2023	BUY	$30.02 - $38.81 $267,838 - $346,262	8,922 New	8,922 $292,000

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.62B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.